Microbot Medical Inc. announced on September 16, 2025, the first closing of the exercise of certain outstanding preferred investment options. This initial closing generated approximately $25.2 million in gross proceeds for the company.
The exercise involved the purchase of 12,064,627 shares of common stock, with exercise prices ranging from $1.50 to $2.13 per share. In consideration for these exercises, Microbot issued new unregistered short-term series J preferred investment options to the holders.
A second closing of the offering is expected by October 15, 2025, which is anticipated to generate approximately $4 million in additional gross proceeds. Furthermore, the new short-term series J preferred investment options, if fully exercised on a cash basis, could provide approximately $63 million in potential additional gross proceeds, significantly bolstering the company's financial resources for continued development and commercialization of the LIBERTY Robotic System.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.